Aspicio Therapeutics, Inc.

New Filing
CIK: 0002025735·Other Health Care·DELAWARE·Filed: Jun 21, 2024
Total Offering

$400,000

Amount Sold

$400,000

Investors

3

First Sale

Jun 18, 2024

Offering Details

Type
Option to Acquire, Security to be Acquired
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2024
Non-Accredited Investors
No

Related Persons

NameRole
Michael Keane
Related Person

Company

Aspicio Therapeutics, Inc.

250 TRUMAN WAY

DOWNINGTON, PA, 19335

484.885.4744

SEC Filing

0002025735-24-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Aspicio Therapeutics, Inc. Form D Filing — $400,000 | FilingFlow